000 01263 a2200313 4500
005 20250513110430.0
264 0 _c19970306
008 199703s 0 0 eng d
022 _a1120-009X
024 7 _a10.1179/joc.1996.8.6.465
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFlandina, C
245 0 0 _aDevelopment and partial characterization of a human T-lymphoblastic leukemic (CCRF-CEM) cell line resistant to etoposide. Analysis of possible circumventing approaches.
_h[electronic resource]
260 _bJournal of chemotherapy (Florence, Italy)
_cDec 1996
300 _a465-71 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aDrug Resistance, Multiple
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aEtoposide
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLeukemia, T-Cell
_xmetabolism
650 0 4 _aTumor Cells, Cultured
_xdrug effects
700 1 _aFlugy, A
700 1 _aBorsellino, N
700 1 _aD'Alessandro, N
773 0 _tJournal of chemotherapy (Florence, Italy)
_gvol. 8
_gno. 6
_gp. 465-71
856 4 0 _uhttps://doi.org/10.1179/joc.1996.8.6.465
_zAvailable from publisher's website
999 _c8972667
_d8972667